Status:
COMPLETED
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis
Lead Sponsor:
Psychiatric University Hospital, Zurich
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This randomised three-arm study aims to evaluate the efficacy and feasibility of a cognitive behavioral therapy (INT-Integrated Neurocognitive Therapy for Schizophrenia Patients) in the treatment of s...
Detailed Description
Psychotic disorders, and particularly schizophrenia, are severe psychiatric disorders, characterized by psychotic symptoms (mainly hallucinations and delusions), disorganized speech, thought and behav...
Eligibility Criteria
Inclusion
- Participants are competent to give informed consent.
- Diagnosis of Schizophrenia or Schizoaffective Disorder (ICD-10).
- Participants are between 18 and 65 years of age.
- Fulfillment of regular compulsory education.
- German language proficiency as a native speaker or level B1
Exclusion
- Unwilling or unable to comply with study instructions.
- Low Intelligence as stated by failure to accomplish regular compulsory education.
- Currently in another psychotherapeutic treatment, either in individual or group sessions.
- Current consumption of Alcohol or illicit Drugs.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT03316664
Start Date
June 1 2018
End Date
August 31 2021
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatrische Universitätsklinik Zürich
Zurich, Switzerland, 8032